Terms: = Brain cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
12 results:
1. New treatment strategies for human epidermal growth factor receptor 2-positive breast cancer in 2023.
Banys-Paluchowski M; Krawczyk N; Stickeler E; Müller V; Fehm T
Curr Opin Obstet Gynecol; 2023 Feb; 35(1):54-61. PubMed ID: 36239554
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome After Endovascular Treatment in Patients With Active cancer and Ischemic Stroke: A MR CLEAN Registry Substudy.
Verschoof MA; Groot AE; de Bruijn SFTM; Roozenbeek B; van der Worp HB; Dippel DWJ; Emmer BJ; Roosendaal SD; Majoie CBLM; Roos YBWEM; Coutinho JM;
Neurology; 2022 Mar; 98(10):e993-e1001. PubMed ID: 35017306
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Alterations in Sporadic Pituitary Tumors.
Bi WL; Larsen AG; Dunn IF
Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
[TBL] [Abstract] [Full Text] [Related]
4. The promises of immunotherapy in gliomas.
Mildenberger I; Bunse L; Ochs K; Platten M
Curr Opin Neurol; 2017 Dec; 30(6):650-658. PubMed ID: 28984704
[TBL] [Abstract] [Full Text] [Related]
5. clinical Relevance of Steroid Use in Neuro-Oncology.
Ly KI; Wen PY
Curr Neurol Neurosci Rep; 2017 Jan; 17(1):5. PubMed ID: 28138871
[TBL] [Abstract] [Full Text] [Related]
6. IDH1, lipid metabolism and cancer: Shedding new light on old ideas.
Bogdanovic E
Biochim Biophys Acta; 2015 Sep; 1850(9):1781-5. PubMed ID: 25960387
[TBL] [Abstract] [Full Text] [Related]
7. Translating genomic discoveries to the clinic in pediatric oncology.
Glade Bender J; Verma A; Schiffman JD
Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
[TBL] [Abstract] [Full Text] [Related]
9. Malignant astrocytoma in elderly patients: where do we stand?
Tabatabai G; Stupp R; Wick W; Weller M
Curr Opin Neurol; 2013 Dec; 26(6):693-700. PubMed ID: 24152817
[TBL] [Abstract] [Full Text] [Related]
10. New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright.
Weber DC; Lovblad KO; Rogers L
Curr Opin Neurol; 2010 Dec; 23(6):563-70. PubMed ID: 20885321
[TBL] [Abstract] [Full Text] [Related]
11. Meningioma: an update.
Lusis E; Gutmann DH
Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of single photon emission computerised tomography (SPECT) using Tc99m-tetrofosmin as a diagnostic modality for recurrent posterior fossa tumours.
Barai S; Bandopadhayaya GP; Julka PK; Haloi AK; Seith A; Malhotra A
J Postgrad Med; 2003; 49(4):316-20; discussion 320-1. PubMed ID: 14699229
[TBL] [Abstract] [Full Text] [Related]
